1. Home
  2. DRI vs ROIV Comparison

DRI vs ROIV Comparison

Compare DRI & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Darden Restaurants Inc.

DRI

Darden Restaurants Inc.

N/A

Current Price

$194.98

Market Cap

22.2B

ML Signal

N/A

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

N/A

Current Price

$34.14

Market Cap

23.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DRI
ROIV
Founded
1968
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.2B
23.2B
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
DRI
ROIV
Price
$194.98
$34.14
Analyst Decision
Buy
Strong Buy
Analyst Count
25
9
Target Price
$226.50
$28.94
AVG Volume (30 Days)
1.6M
5.9M
Earning Date
03-19-2026
05-28-2026
Dividend Yield
3.06%
N/A
EPS Growth
4.11
N/A
EPS
6.87
N/A
Revenue
$12,076,700,000.00
$8,260,000.00
Revenue This Year
$10.58
N/A
Revenue Next Year
$3.73
$744.61
P/E Ratio
$28.38
N/A
Revenue Growth
6.03
N/A
52 Week Low
$169.00
$10.90
52 Week High
$220.65
$37.00

Technical Indicators

Market Signals
Indicator
DRI
ROIV
Relative Strength Index (RSI) 36.93 54.78
Support Level $191.78 $26.65
Resistance Level $201.81 $37.00
Average True Range (ATR) 5.47 1.06
MACD -1.29 -0.34
Stochastic Oscillator 0.00 23.00

Price Performance

Historical Comparison
DRI
ROIV

About DRI Darden Restaurants Inc.

Darden Restaurants is the largest global full-service dining operator, with over $12 billion in system sales across 2,159 company-owned stores at the end of fiscal 2025, spanning the US and Canada. The firm operates 10 banners in four segments, including Olive Garden (43% of sales), LongHorn Steakhouse (25%), and fine dining (21%), which includes The Capital Grille, Ruth's Chris, and Eddie V's. The other 11% of sales comes from smaller concepts such as Yard House and Cheddar's. Darden primarily generates revenue through sales of food and beverage items at its company-owned restaurants. It also earns royalties on sales from 154 franchised locations in US and international markets, which sit within the other segment but are immaterial to consolidated results.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: